Roche Venture Fund

Overview

Roche's corporate venture arm, an evergreen fund of CHF 750 million (per Roche's own current site) investing in pharmaceuticals, diagnostics and digital health, typically at Series A with CHF 5-10 million initial checks (up to CHF 25 million, ~15-20% stakes). Offices in Basel and South San Francisco; 30+ portfolio companies including Freenome and Black Diamond Therapeutics.

Key Facts

Type

Corporate Venture Capital

Geography focus

Global (life sciences hubs, primarily North America and Europe)